trial

Early Psychosis: Investigating Cognition

NCTId NCT07196423
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 106 (estimated)
Sponsored by University of Nottingham
Primary completion 2027-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
106 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2026-02-09
Primary completion
2027-08
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
transcranial direct current stimulation (tDCS)Magnetic Resonance Imaging

Sponsors

University of NottinghamLead Sponsor
Wellcome TrustCollaborator

Investigators

1
Claudia Danielmeier, PhDPrincipal Investigator

Sites

1 total
Nottingham, United Kingdom

Facts & assertions

4 sourced
Enrollment
106
Phase
NA
Primary Completion Date
2027-08
Status
RECRUITING
relationships
The graph out of here
drug
transcranial direct current stimulation (tDCS)
drug
Magnetic Resonance Imaging
drug
lead_sponsor
University of Nottingham
company
collaborator
Wellcome Trust
company
indication
Psychosis
indication
First Episode Psychosis (FEP)
indication
Psychotic Disorders
indication
investigator
Claudia Danielmeier, PhD
person